SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-23-000947
Filing Date
2023-02-14
Accepted
2023-02-14 06:03:07
Documents
54
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nbio_10q.htm   iXBRL 10-Q 659824
2 CERTIFICATION nbio_ex311.htm EX-31.1 12927
3 CERTIFICATION nbio_ex312.htm EX-31.2 10825
4 CERTIFICATION nbio_ex321.htm EX-32.1 4839
5 CERTIFICATION nbio_ex322.htm EX-32.2 4966
  Complete submission text file 0001477932-23-000947.txt   3424344

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nbio-20221231.xsd EX-101.SCH 48500
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20221231_lab.xml EX-101.LAB 251776
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20221231_cal.xml EX-101.CAL 34658
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20221231_pre.xml EX-101.PRE 207169
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20221231_def.xml EX-101.DEF 107416
48 EXTRACTED XBRL INSTANCE DOCUMENT nbio_10q_htm.xml XML 384907
Mailing Address 631 US HWY 1, SUITE 407 NORTH PALM BEACH FL 33408
Business Address 631 US HWY 1, SUITE 407 NORTH PALM BEACH FL 33408 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55299 | Film No.: 23621723
SIC: 2834 Pharmaceutical Preparations